Compare Hinge Health Inc. Class A Common Stock (HNGE) vs The Coca-Cola Co K (KO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Hinge Health Inc. Class A Common Stock vs The Coca-Cola Co K — how do they compare? Hinge Health Inc. Class A Common Stock trades at $104.95 (market cap $8.48B), while The Coca-Cola Co K trades at $92.2 (market cap $387.70B). The key difference: The Coca-Cola Co K is far larger — about 45.7× Hinge Health Inc. Class A Common Stock's market cap, and The Coca-Cola Co K pays a 2.35% dividend while Hinge Health Inc. Class A Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Hinge Health Inc. Class A Common Stock for 0 Days and The Coca-Cola Co K for 154 Days on average.
| HNGE | KO | |
|---|---|---|
Market Cap | $8.48B | $387.70B |
Volume | 879,799 | 15,313,783 |
Sector | Health | Consumer Staples |
52-Week High | $105.14 | $91.99 |
52-Week Low | $31.17 | $67.08 |
Typical Hold Time | 0 Days | 154 Days |
Enterprise Value | $8.10B | $414.87B |
Dividend Yield | — | 2.35% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Hinge Health (HNGE) trades at $105.14, up 0.31% on the day and near its 52-week high. The stock shows strong analyst support with a 93.75% buy rating, though the current price exceeds the consensus target of $101.62. Recent earnings beat expectations in two of the last three quarters, with Q3 2026 results due November 2. Fundamentals indicate robust revenue growth projections from $588 million in 2025 to $720 million in 2026, alongside a shift to profitability, but valuation multiples like EV/EBITDA at 82.33 remain elevated.
The outlook is cautiously optimistic given projected profitability and expansion into migraine and GI care, but risks include high insider selling, competitive pressures, and the stock's premium valuation. Execution on growth targets and Q3 earnings will be critical for sustaining momentum.
Coca-Cola (KO) trades at $91.78, up 2.22% today, with a bullish technical outlook supported by moving averages and a consensus analyst price target of $95.75. The company reported strong earnings beats in recent quarters, with Q2 2026 EPS of $0.97 exceeding expectations, and maintains robust profitability with a 28.56% net income margin. Recent news highlights institutional buying and stable demand trends, though RSI levels indicate potential near-term overbought conditions.
The stock offers a solid dividend profile with 64 consecutive years of increases, but faces risks from regional demand divergence and high valuation multiples. Upside is supported by earnings momentum and institutional accumulation, while macroeconomic pressures and elevated P/E of 27.06 pose caution. The balance between growth execution and market sentiment will drive near-term performance.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Hinge Health Inc. Class A Common Stock
Hinge Health Inc. operates a digital musculoskeletal (MSK) care platform that delivers exercise therapy for joint and muscle conditions through health plans and employers. Its Precision Motion Technology combines wearable sensors and computer vision to guide patients through clinician-directed physical therapy remotely.
Read more on HNGE →About The Coca-Cola Co K
The Coca-Cola Company manufactures, markets, and distributes soft drink concentrates and syrups. The Company also distributes and markets juice and juice-drink products. Coca-Cola distributes its products to retailers and wholesalers in the United States and internationally.
Read more on KO →
